3-methyladenosine has been researched along with chloroquine in 2 studies
| Studies (3-methyladenosine) | Trials (3-methyladenosine) | Recent Studies (post-2010) (3-methyladenosine) | Studies (chloroquine) | Trials (chloroquine) | Recent Studies (post-2010) (chloroquine) |
|---|---|---|---|---|---|
| 11 | 0 | 7 | 16,405 | 763 | 4,029 |
| Protein | Taxonomy | 3-methyladenosine (IC50) | chloroquine (IC50) |
|---|---|---|---|
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 43 | |
| Spike glycoprotein | Betacoronavirus England 1 | 5.47 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 5.47 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 5.47 | |
| Dihydrofolate reductase | Bos taurus (cattle) | 0.0301 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 7 | |
| Histidine-rich protein PFHRP-II | Plasmodium falciparum (malaria parasite P. falciparum) | 0.2383 | |
| Procathepsin L | Homo sapiens (human) | 5.47 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 5.47 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 5.47 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 5.47 | |
| Spike glycoprotein | Severe acute respiratory syndrome coronavirus 2 | 3.58 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.375 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 1.5 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.27 | |
| Beta-secretase 1 | Homo sapiens (human) | 7 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 5.47 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.503 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 6.235 | |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 0.02 | |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boldorini, R; Canonico, PL; Di Lisa, F; Drago, V; Galli, U; Genazzani, AA; Kaludercic, N; Maldi, E; Travelli, C; Tron, GC | 1 |
| Cheng, Y; Liu, D; Patel, R; Qin, ZH; Ren, X; Shih, IM; Wu, H; Yang, JM; Yap, KL; Zhang, L; Zhang, Y | 1 |
2 other study(ies) available for 3-methyladenosine and chloroquine
| Article | Year |
|---|---|
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells.
Topics: Acrylamides; Adenosine; Adenosine Triphosphate; Annexin A5; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Autophagy; Autophagy-Related Protein 7; Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Survival; Chloroquine; Cisplatin; Comet Assay; DNA Damage; Down-Regulation; Drug Synergism; Etoposide; Humans; Immunohistochemistry; L-Lactate Dehydrogenase; Neuroblastoma; Nicotinamide Phosphoribosyltransferase; Piperidines; Ubiquitin-Activating Enzymes | 2011 |
NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Antineoplastic Agents, Alkylating; Autophagy; Cell Line, Tumor; Cell Survival; Chloroquine; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression; Gene Knockdown Techniques; HMGB1 Protein; Humans; Microtubule-Associated Proteins; Neoplasm Proteins; Ovarian Neoplasms; Protein Transport; Repressor Proteins; RNA Interference; Sequestosome-1 Protein | 2012 |